Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Using the National PulsePoint Cardiopulmonary Resuscitation Responder Network to Facilitate Overdose Education and Naloxone Distribution

NCT06523985 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT06523985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06523985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Using the National PulsePoint Cardiopulmonary Resuscitation Responder Network to Facilitate Overdose Education and Naloxone Distribution
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 7, 2024
Completion date
October 31, 2026
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

being trained to respond to an opioid overdose, carrying naloxone/narcan on their person or in their vehicle